Literature DB >> 22618236

Decalpenic acid induces early osteoblastic markers in pluripotent mesenchymal cells via activation of retinoic acid receptor γ.

Shuichi Sakamoto1, Fukiko Kojima, Isao Momose, Manabu Kawada, Hayamitsu Adachi, Yoshio Nishimura.   

Abstract

Decalpenic acid is a natural small molecule previously isolated from the fermentation broth of fungi that induces early osteoblastic markers in pluripotent mesenchymal cells. Treatment of mouse pluripotent mesenchymal C3H10T1/2 cells with decalpenic acid gave rise to a morphological change similar to that induced by the treatment with retinoic acid, i.e. the cells adopted a more elongated spindle shape. Using a retinoic acid response element reporter and receptor activity assays, we show that decalpenic acid is a new retinoid with selectivity towards retinoic acid receptors γ and α. The induction of early osteoblastic markers by decalpenic acid was significantly inhibited by treatment with the retinoid antagonist, LE540, or with small interfering RNA-mediated knockdown of retinoic acid receptor γ. These results demonstrated that decalpenic acid induces early osteoblastic markers in pluripotent mesenchymal cells through activation of retinoic acid receptor γ.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618236     DOI: 10.1016/j.bbrc.2012.05.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Authors:  Hayamitsu Adachi; Koichi Nakae; Shuichi Sakamoto; Chisato Nosaka; Sonoko Atsumi; Masabumi Shibuya; Nobuaki Higashi; Motowo Nakajima; Tatsuro Irimura; Yoshio Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

2.  Phenazine carboxylic acid and its derivative induce osteoblast differentiation in preosteoblastic MC3T3-E1 cells but adipocyte differentiation in pluripotent mesenchymal C3H10T1/2 cells.

Authors:  Shuichi Sakamoto; Takumi Watanabe; Yasuko Kohda; Masatomi Iijima; Ryuichi Sawa; Maiko Okada; Hayamitsu Adachi; Yoshio Nishimura; Manabu Kawada
Journal:  J Antibiot (Tokyo)       Date:  2017-10-25       Impact factor: 2.649

3.  Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.

Authors:  Jacqueline E Noll; Sharon A Williams; Christine M Tong; Hongsheng Wang; Julie M Quach; Louise E Purton; Katherine Pilkington; Luen B To; Andreas Evdokiou; Stan Gronthos; Andrew C W Zannettino
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

4.  Combined Effects of Soy Isoflavones and β-Carotene on Osteoblast Differentiation.

Authors:  Yoriko Nishide; Yuko Tousen; Miki Tadaishi; Masaki Inada; Chisato Miyaura; Marlena C Kruger; Yoshiko Ishimi
Journal:  Int J Environ Res Public Health       Date:  2015-10-28       Impact factor: 3.390

5.  Interferon-Induced Transmembrane Protein 1 (IFITM1) Promotes Distant Metastasis of Small Cell Lung Cancer.

Authors:  Shuichi Sakamoto; Hiroyuki Inoue; Yasuko Kohda; Shun-Ichi Ohba; Taketoshi Mizutani; Manabu Kawada
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

6.  Generation and evaluation of a chimeric antibody against coxsackievirus and adenovirus receptor for cancer therapy.

Authors:  Shuichi Sakamoto; Hiroyuki Inoue; Mika K Kaneko; Satoshi Ogasawara; Masunori Kajikawa; Sakiko Urano; Shun-Ichi Ohba; Yukinari Kato; Manabu Kawada
Journal:  Cancer Sci       Date:  2019-09-28       Impact factor: 6.716

7.  Lycopene influences osteoblast functional activity and prevents femur bone loss in female rats submitted to an experimental model of osteoporosis.

Authors:  Gustavo Ribeiro Oliveira; Paula Katherine Vargas-Sanchez; Roger Rodrigo Fernandes; Milla Sprone Tavares Ricoldi; Mayara Sgarbi Semeghini; Dimitrius Leonardo Pitol; Luiz Gustavo de Sousa; Selma Siessere; Karina Fittipaldi Bombonato-Prado
Journal:  J Bone Miner Metab       Date:  2018-10-24       Impact factor: 2.626

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.